Relief Therapeutics Holding SA / Key word(s): Patent Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate 03-Oct-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to .
Relief Therapeutics Holding SA / Key word(s): Patent Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate
Relief Therapeutics Holding SA / Key word(s): Patent03-Oct-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Cove.
Relief Therapeutics Holding SA / Key word(s): Study22-Sep-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epid.
Relief Therapeutics Holding SA / Key word(s): Study Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children s Hospital of Chicago 22-Sep-2022 / 07:00 CET/CEST Release of an ad hoc anno.